SQ109, a New Drug Lead for Chagas Disease
We tested the antituberculosis drug SQ109, which is currently in advanced clinical trials for the treatment of drug-susceptible and drug-resistant tuberculosis, for its in vitro activity against the trypanosomatid parasite Trypanosoma cruzi, the causative agent of Chagas disease. SQ109 was found to...
Saved in:
| Published: |
2015
|
|---|---|
| Subjects: | |
| Online Access: | http://hdl.handle.net/10872/15711 |
| Tags: |
No Tags, Be the first to tag this record!
|